Why Should You Put Aquestive Therapeutics Inc (NASDAQ: AQST) On Your Portfolio?

Currently, there are 99.32M common shares owned by the public and among those 87.98M shares have been available to trade. The company’s stock has a 5-day price change of -14.87% and -22.90% over the past three months. AQST shares are trading -35.67% year to date (YTD), with the 12-month market performance down to -30.40% lower. […]